SCWorx Corp. filings document the regulatory record for a healthcare SaaS data management company and its common stock. The company’s 8-K reports cover Nasdaq minimum-bid-price notices, reverse stock split actions, warrant inducement agreements, and other material events tied to capital structure and listing compliance.
Its registration and proxy filings describe securities offerings, common stock and warrant issuance, shareholder voting matters, director elections, executive compensation advisory votes, auditor ratification, and Nasdaq Rule 5635(d) share-issuance approvals. These disclosures also frame governance, capital authorization, and financing terms for the business.
SCWorx Corp. received an updated Schedule 13G/A showing revised beneficial ownership by Iroquois-related investors. As of the referenced date, Iroquois Capital Management LLC reported beneficial ownership of 53,477 shares of Common Stock, representing 4.78% of the class, including shares issuable upon exercise of certain warrants subject to Beneficial Ownership Blockers. Richard Abbe reported 115,383 shares, or 9.78%, through a combination of sole and shared voting and dispositive power, while Kimberly Page reported 53,477 shares, or 4.78%, on a shared basis.
Iroquois Master Fund Ltd. held 2,067 shares of Common Stock and warrants to purchase 812,378 shares, and Iroquois Capital Investment Group LLC held 80 shares and warrants to purchase 1,073,835 shares. Many of these warrants are subject to 4.99% or 9.99% Beneficial Ownership Blockers that limit exercisability so ownership does not exceed those thresholds. All reported ownership percentages are based on 1,066,918 shares outstanding as of July 28, 2026 and give effect to the Beneficial Ownership Blockers; they do not reflect a reverse stock split effective August 3, 2026.
SCWorx Corp. approved a 1-for-12 reverse stock split of its common stock, effective at 11:59 p.m. Eastern Time on August 3, 2026. Every twelve shares outstanding will be combined into one share, reducing issued and outstanding shares from 1,066,918 to approximately 89,000.
The number of authorized shares is unchanged, which will significantly increase authorized but unissued shares and could result in substantial dilution if issued. The split is being implemented to help regain compliance with Nasdaq's $1.00 minimum bid price rule by August 28, 2026, but may reduce liquidity, increase volatility and does not guarantee continued Nasdaq listing.
SCWorx Corp. details its efforts to maintain its listing on The Nasdaq Capital Market after previously falling below Nasdaq’s $1.00 per share minimum bid price requirement and receiving a delisting determination.
Following an appeal and a June 17, 2026 Nasdaq Hearings Panel decision granting continued listing subject to conditions, SCWorx received a partial compliance letter on July 24, 2026 confirming it satisfied the first provision of its compliance plan. The company must still comply with all remaining Nasdaq Listing Rules, including maintaining the minimum bid price for 20 consecutive trading days, and states there can be no assurance it will ultimately regain full compliance.
SCWorx Corp. received a Nasdaq notice dated July 24, 2026 stating that its Market Value of Publicly Held Shares (MVPHS) did not meet the required minimum of $1,000,000 for 30 consecutive business days, from June 10, 2026 through July 23, 2026, under Nasdaq Listing Rule 5550(a)(5).
This triggers a 180‑day compliance period through January 20, 2027. If at any time in that period SCWorx’s MVPHS is at least $1,000,000 for a minimum of ten consecutive business days (or a longer period Nasdaq may require, up to twenty days), Nasdaq will confirm compliance. The company is reviewing alternatives to regain and sustain compliance; as of the date of the report, the board had not chosen a specific course of action. Failure to regain compliance would subject the common stock to delisting, though SCWorx could appeal, with no assurance of success.
SCWorx Corp. held its 2026 Annual Meeting of Stockholders on July 22, 2026. Stockholders elected directors Timothy A. Hannibal, Troy Kirchenbauer, Vincent Matozzo and Michael Burke to serve until the next annual meeting and until their successors are elected and qualified.
In a non-binding advisory vote on executive compensation, stockholders cast 112,820 votes for, 128,981 against and 1,394 abstentions, so the compensation of named executive officers was not approved. Stockholders ratified Astra Audit & Advisory, LLC as independent auditors for the year ended December 31, 2026, with 446,290 votes for and 24,963 against.
Stockholders also approved an amendment to the certificate of incorporation to authorize a reverse stock split of common stock, at a ratio within the range of 1/1.5 and 1/20, at the board’s discretion, if needed to regain compliance with Nasdaq Rule 5550(a)(2) requiring a minimum $1.00 bid price.
SCWorx Corp. received a decision from a Nasdaq Hearings Panel allowing its common stock to continue listing on Nasdaq, subject to strict compliance conditions. Trading had been suspended after the stock failed to meet the Nasdaq minimum bid price of $1.00 per share.
To regain trading on Nasdaq, SCWorx must obtain shareholder approval for a reverse stock split by July 22, 2026, implement the reverse split by August 3, 2026, and then demonstrate a closing bid of at least $1.00 per share for 20 consecutive trading days by August 28, 2026. If it fails, the stock would remain quoted on OTC Markets, where it has approval for quotation on the OTCQB Market.
SCWorx Corp. is asking shareholders to approve corporate matters at its Annual Meeting on July 22, 2026, including election of four directors, ratification of Astra Audit & Advisory, LLC as auditor, an advisory vote on executive compensation, and authorization for a possible reverse stock split in the range of 1-for-1.5 to 1-for-20.
The proxy states there were 1,066,918 shares of Common Stock and 39,810 shares of Series A Preferred Stock (convertible into 75,915 common shares) outstanding as of the record date of June 9, 2026. The Board may effect a reverse split if it determines it is needed to meet Nasdaq minimum bid requirements.
SCWorx Corp. is asking shareholders at its July 22, 2026 annual meeting to elect four directors, approve executive pay on an advisory basis, ratify Astra Audit & Advisory as auditor for 2026, and authorize a potential reverse stock split.
The reverse split, at a ratio between 1‑for‑1.5 and 1‑for‑10, would be used on an “as needed” basis to help lift the share price to at least $1.00 and support efforts to regain a Nasdaq Capital Market listing. SCWorx currently has 1,066,918 common shares and 39,810 Series A preferred shares outstanding as of June 9, 2026, with each common and as‑converted preferred share entitled to one vote.
SCWorx Corp. proposes standard annual meeting items and seeks shareholder approval for a discretionary reverse stock split. The proxy solicits votes to elect four directors, approve executive compensation on a non-binding basis, ratify Astra Audit & Advisory, LLC as auditor, and approve an amendment permitting a reverse stock split in a ratio between 1-for-1.5 and 1-for-10 to target a minimum $1.00 bid price under Nasdaq Rule 5550(a)(2). The Board notes prior Nasdaq delisting actions in April 2026 and describes procedures for implementing a split if approved.
The proxy discloses governance details (committee composition and meeting frequency), executive and director compensation summaries, related-party advances and audit fees, and instructions for voting by proxy or in person at the meeting planned for July __, 2026.
SCWorx Corp. reports Q1 2026 results with modest revenue growth and a sharply reduced loss. Revenue was $744,899, up slightly from $720,299 a year earlier. Cost of revenue dropped to $370,790, lifting gross profit to $374,109 from $136,863.
Operating expenses rose to $509,923, mainly from higher salaries and new stock-based compensation, but interest expense fell as all prior convertible notes were converted to equity. Net loss narrowed to $173,767 from $476,303. Cash was $1.34 million at March 31, 2026, down from $1.64 million at year-end.
The company implemented a 1-for-15 reverse stock split effective April 10, 2026. Nasdaq has notified SCWorx that its shares will be delisted for failing to meet the $1.00 minimum bid price; trading was suspended April 14, 2026, and the company has appealed. Management also reports that disclosure controls and procedures were not effective due to control design deficiencies and lack of segregation of duties.